Guilei Ma

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Reduced Graphene Oxide

Dendritic Cells

Immune Response

Rheumatoid Arthritis Patients

Top Venues

Advanced healthcare materials

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Lu, Yonghua Gong, Xianghui Zhu, Xia Dong, Dunwan Zhu, Guilei Ma
Design of Light-Activated Nanoplatform through Boosting "Eat Me" Signals for Improved CD47-Blocking Immunotherapy. Advanced healthcare materials 11 (10) (2022)
Xiao Li Wang, Zuoguan Chen, Chao Zhang, Chuangnian Zhang, Guilei Ma, Jing Yang, Xiaoqing Wei, Hongfan Sun
A Generic Coordination Assembly-Enabled Nanocoating of Individual Tumor Cells for Personalized Immunotherapy. Advanced healthcare materials 8 (17) (2019)
Yijia Liu, Xianghui Zhu, Yan Lu, Xiaoli Wang, Chuangnian Zhang, Hongfan Sun, Guilei Ma
Antigen-Inorganic Hybrid Flowers-Based Vaccines with Enhanced Room Temperature Stability and Effective Anticancer Immunity. Advanced healthcare materials 8 (21) (2019)
Mengmeng Yan, Yijia Liu, Xianghui Zhu, Xiao Li Wang, Lanxia Liu, Hongfan Sun, Chun Wang, De Ling Kong, Guilei Ma
Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity. ACS applied materials & interfaces 11 (2) (2019)
Fengqiang Cao, Mengmeng Yan, Yijia Liu, Lanxia Liu, Guilei Ma
Photothermally Controlled MHC Class I Restricted CD8+ T-Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy. Advanced healthcare materials 7 (10) (2018)
Jiale Liu, Xiaoxuan Liu, Yanfeng Han, Jing Zhang, Dan Liu, Guilei Ma, Chen Li, Lanxia Liu, De Ling Kong
Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses. ACS applied materials & interfaces 10 (37) (2018)